In practice, many obesity specialists have found themselves deviating from the label slowing down titration, adding intermediate doses, maintaining lower doses longer, or skipping weeks to help patients stay on therapy
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Isolated, sharp throat tightness immediately after swallowing a pill is almost exclusively a mechanical spasm and chemical irritation of the esophagus (the food tube), entirely unrelated to the trachea (the windpipe)
Post-Thyroidectomy Patients Generally safe if thyroid levels are controlled
We do see a slight pullback in the overall basket, just less units, slightly less calories
